Latest News

The United States market remained flat over the last week but has experienced a 16% rise over the past 12 months, with earnings projected to grow by 15% annually in the coming years. In this context, identifying high growth tech stocks involves focusing on companies that demonstrate strong innovation and scalability potential, aligning with current market conditions and future growth expectations.

In the last week, the United States market has stayed flat, though it has risen by 16% over the past year with earnings forecasted to grow by 15% annually. In such an environment, identifying stocks priced below their estimated value can offer opportunities for investors seeking potential growth and value.

Fengate Asset Management has expanded its renewable energy portfolio by acquiring a 50% interest in a 227 MWac portfolio of 12 operational solar projects across the western United States. This acquisition forms part of a joint venture with Clearway Energy Inc., enhancing Fengate's strategic focus on energy transition initiatives. Managed under the Fengate Infrastructure Yield Fund, this investment aligns with the company's objective to engage in long-term contracted renewable projects,...

The recent price decline of 14% in Kane Biotech Inc.'s ( CVE:KNE ) stock may have disappointed insiders who bought...

Over the last 7 days, the United States market has remained flat, but it is up 16% over the past year with earnings forecast to grow by 15% annually. In this environment, growth companies with high insider ownership can be appealing as they often demonstrate strong alignment between management and shareholders, potentially leading to robust performance.

Over the last 7 days, the United States market has remained flat, yet it is up 16% over the past year with earnings forecast to grow by 15% annually. For investors willing to explore beyond well-known stocks, penny stocks can offer intriguing opportunities that align with current market conditions. Although the term 'penny stocks' may seem outdated, they continue to represent a viable investment area for those seeking affordability and growth potential in smaller or newer companies.

The United States market remained flat over the last week, yet it has experienced a 16% rise over the past year with earnings forecasted to grow by 15% annually. In such an environment, identifying promising stocks often involves looking for companies with strong growth potential and unique value propositions that may not yet be widely recognized.

The United States market has seen a steady performance, remaining flat over the last week but showing a robust 16% increase over the past year, with earnings projected to grow by 15% annually. In such an environment, identifying top dividend stocks involves looking for companies with strong fundamentals and consistent dividend payouts that can offer stability and potential income growth amidst fluctuating market conditions.

How Helens International Holdings' Latest Numbers Stack Up Helens International Holdings (SEHK:9869) has just posted FY 2025 first half results with revenue of C¥291.8 million and basic EPS of C¥0.040, alongside trailing twelve month revenue of C¥540.5 million and EPS of C¥0.027 as the share price sits at HK$0.84. Over recent periods, the company has seen reported revenue move from C¥441.5 million in 1H 2024 to C¥291.8 million in 1H 2025, while net income shifted from C¥69.7 million to C¥50.3...

BrainAurora Medical Technology (SEHK:6681) has laid out its FY 2025 scorecard with first half revenue of C¥100.1 million and a basic EPS loss of C¥0.11, alongside net income excluding extra items of a C¥126.4 million loss. The company has seen revenue move from C¥51.9 million in 1H 2024 to C¥70.4 million in 2H 2024 and then to C¥100.1 million in 1H 2025. Trailing twelve month EPS stands at a loss of C¥0.20 on net income excluding extra items of a C¥210.3 million loss, so investors are left...

China MeiDong Auto Holdings (SEHK:1268) has just posted FY 2025 first half results with revenue of C¥10.1b and a basic EPS loss of C¥0.61, keeping the spotlight firmly on profitability and margins. Over the last three reported half year periods, revenue has moved from C¥10.7b in 1H 2024 to C¥11.5b in 2H 2024 and now C¥10.1b in 1H 2025. Over the same periods, basic EPS has shifted from a small loss of C¥0.02 in 1H 2024 to a larger loss of C¥1.66 in 2H 2024 and C¥0.61 in 1H 2025. The current...

Beijing Airdoc Technology (SEHK:2251) has reported its FY 2025 first half with revenue of ¥83.7 million and a basic EPS loss of ¥0.016, while trailing twelve month figures show revenue of ¥146.4 million and a basic EPS loss of ¥1.73. Over recent periods, the company has seen revenue move between ¥93.7 million in 1H 2024 and ¥62.7 million in 2H 2024 alongside net income losses of ¥80.5 million and ¥175.0 million respectively. This underlines that the top line has not yet translated into...

SPIE (ENXTPA:SPIE) has been in focus after two recent project wins: a new IP-based communications platform for a major German hospital group and high-power electric truck charging stations on French motorways. See our latest analysis for SPIE. Those new contracts land at a time when SPIE’s share price, now at €43.94, has seen a 1 month share price return of 15.66% decline and a 90 day share price return of 10.80% decline. However, the 5 year total shareholder return of 141.24% points to a...

Zhejiang Expressway (SEHK:576) has reported full year 2025 results with fourth quarter revenue of C¥5.6b and basic EPS of C¥0.19, setting the stage for investors to reassess how earnings quality and margins are evolving. Over recent quarters the company has seen revenue range from C¥4.3b to C¥5.6b and quarterly EPS move between C¥0.19 and C¥0.25. Trailing 12 month EPS sits at C¥0.89 on revenue of C¥19.8b and net income of C¥5.3b, so the latest print lands in the context of solid absolute...

Tencent Music Entertainment Group, NYSE:TME, is facing increased competitive pressure from emerging platforms such as Soda Music. Financial institutions are flagging artificial intelligence as a key factor that could reshape the company outlook and the broader digital music market. These developments raise new questions about the long term position of NYSE:TME in China’s online music and audio space. Tencent Music Entertainment Group, NYSE:TME, last closed at $9.19, with the share price...

If you are trying to work out whether Blackstone is genuinely good value or just an expensive brand name, the recent share price moves give you plenty to think about. The stock closed at US$114.33, with a 5.5% gain over the last 7 days, a 0.9% decline over 30 days, a 28.0% decline year to date, and a 19.9% decline over 1 year, while the 3 year and 5 year returns sit at 54.1% and 80.2% respectively. Recent headlines around Blackstone have focused on its position as a major global alternative...

Why Hycroft Mining Holding Is Back On Traders’ Radar Hycroft Mining Holding (HYMC) is drawing fresh attention as precious metals prices recover and geopolitical headlines shift sentiment toward miners, while a higher short interest level adds an extra layer of trading focus. See our latest analysis for Hycroft Mining Holding. At a share price of $35.05, Hycroft’s recent 1 day share price slip contrasts with a 47.45% 90 day share price return and a very large 1 year total shareholder return...

In March 2026, Recursion Pharmaceuticals reported an expanded partnership with Citeline to integrate real-world data into its AI-enabled drug development platform, and announced that oncology veteran Vicki Goodman, M.D., will become Chief Medical Officer as of April 6, 2026, succeeding David Mauro, M.D., Ph.D. Together, the data partnership and leadership change highlight Recursion’s push to strengthen clinical execution, particularly in oncology, by combining advanced analytics with deep...

Smart-Core Holdings (SEHK:2166) has just put fresh numbers on the table, with first half FY 2025 revenue of HK$2.8b and basic EPS of HK$0.10, set against trailing twelve month EPS of HK$0.35. Over recent periods, the company has seen revenue move from HK$2,623.9m in 1H FY 2024 to HK$2,024.0m in 2H FY 2024 and then to HK$2,796.2m in 1H FY 2025, while basic EPS shifted from HK$0.08 to HK$0.14 and then to HK$0.10. With a trailing net profit margin of 2.4% versus 2.2% a year earlier, investors...

In March 2026, HUBER+SUHNER and Aurora Networks announced a collaboration to help Vodafone Germany deploy Distributed Access Architecture and virtual CMTS technologies across its live cable network, enhancing speed, reliability and operational efficiency. This partnership underscores how Vistance Networks’ ecosystem is moving critical processing closer to end users, potentially making its virtualized broadband platforms more central to telecom infrastructure upgrades. We’ll now examine how...

Justin Allen Holdings (SEHK:1425) has opened FY 2025 with first half revenue of HK$362.2 million, net income of HK$30.4 million and basic EPS of HK$0.024, setting a measured tone for its latest results. The company has seen revenue move from HK$385.1 million in 1H 2024 to HK$362.2 million in 1H 2025, while EPS shifted from HK$0.034 to HK$0.024 over the same periods, giving you a clear line of sight on how the top and bottom line are tracking into the new financial year. With a trailing net...

Yuanda China Holdings (SEHK:2789) has reported its FY 2025 first half results with revenue of C¥1.27b and basic EPS of C¥0.029659, while trailing twelve month figures show revenue of C¥2.39b paired with a loss of C¥175.82m on a basic EPS of C¥0.028317. The company has seen revenue move from C¥1.09b in the first half of 2024 to C¥1.27b in the first half of 2025, with basic EPS shifting from C¥0.000962 to C¥0.029659 over the same periods. This latest release serves as a test of how far margins...

Jilin Province Huinan Changlong Bio-pharmacy (SEHK:8049) has posted its FY 2025 first half results with revenue of C¥438.9 million and basic EPS of C¥0.184, set against trailing 12 month revenue of C¥901.9 million and EPS of C¥0.355 that came alongside a 7.9% earnings uplift and net profit margins of 22.1%. Over the past year, the company has seen revenue move between C¥881.2 million and C¥926.9 million on a trailing 12 month basis, with basic EPS ranging from C¥0.327 to C¥0.355. This gives a...

JD Health International (SEHK:6618) is back in focus after CF PharmTech selected the company as its exclusive online launch partner for key respiratory and rhinology drugs over the next three years. See our latest analysis for JD Health International. The CF PharmTech agreement comes as JD Health’s share price sits at HK$48.96, with a 7 day share price return of 2.68% but a 30 day share price return decline of 5.76%. The 1 year total shareholder return of 48.36% contrasts with a 3 year total...